TITLE

LIVER DISEASE IN ERYTHROPOIETIC PROTOPORHYRIA: INSIGHTS AND IMPLICATIONS FOR MANAGEMENT

AUTHOR(S)
Anstey, A. V.; Hift, R. J.
PUB. DATE
July 2007
SOURCE
Gut;Jul2007, Vol. 56 Issue 7, p1009
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides information on the condition and management of liver diseases in erythropoietic protoporphyria (EPP). It notes that the clinical expression and progression of the disease remain difficult, thus the identification of possible treatments is hard. Its complexity is further induced because of its low incidence rate to patients with liver diseases. It notes that clinicians who take care for EPP patients must be vigilant on the risk factors associated with the disease.
ACCESSION #
25602411

 

Related Articles

  • An Anthropological Perspective on Behavior and Disease. Katz, Solomon H.; Wallace, Anthony F. C. // American Journal of Public Health;Nov1974, Vol. 64 Issue 11, p1050 

    The article focuses on the significant anthropological relationship between behavior and disease in the U.S. History accounts that there has been an increasing interest in this linkage among the biological and cultural anthropologists. While the biological anthropologists administered disease...

  • Chaparral herbal product causes liver damage.  // NCAHF Newsletter (08903417);Mar/Apr95, Vol. 18 Issue 2, p3 

    Reports on the potential of chapparal herbal products to cause liver damage in humans. Preparation of the herbal products; Chapparal's effects on cancer.

  • liver function, risk for impaired.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1357 

    A definition of the term "liver function, risk for impaired," which refers to the risk for liver dysfunction, is presented.

  • Orlistat-containing medicines under review.  // WHO Drug Information;2011, Vol. 25 Issue 4, p365 

    No abstract available.

  • Where are we now with paracetamol? Important questions remain unanswered about the most widely used drug in the UK. Dear, James W.; Antoine, Daniel J.; Park, B. Kevin // BMJ: British Medical Journal;7/18/2015, Vol. 351 Issue 8017, ph3705 

    The authors reflect on paracetamol, a drug introduced into the medical practice in Great Britain in 1956. Topics discussed include questions regarding the drug's efficiency and safety such as risk of liver injury, rise in alanine transaminase for those with osteoarthritis and potential to...

  • An Overview of Diagnosis. Chaglasian, Michael A. // Review of Optometry;8/15/2010 Supplement, p1 

    The article offers tips on how to cater patients suffering from glaucoma patients in the U.S. It states that physicians need to identify relevant risk factors such as patient's racial and ethnic background. In addition, intraocular pressure (IOP) of the patients must be measured for patients may...

  • Mofezolac: revised data sheet.  // WHO Drug Information;2001, Vol. 15 Issue 1, p25 

    Focuses on the revised data sheet for Mofezolac in Japan. Inclusion of hepatic disorders as adverse reactions of Mofezolac; Assessment on the relationship of Mofezolac with hepatic disorders; Extension on the contraindications of Mofezolac.

  • NO COMFORT IN COMFREY.  // Science Teacher;May2000, Vol. 67 Issue 5, p14 

    Reports on a study showing that the herb comfrey can cause liver damage and should be banned. Use of the herb as a laxative or anti-inflammatory medication; Destruction of small veins, leading to cirrhosis and eventually liver failure; Acute or chronic symptoms; Therapeutic approaches to the...

  • Fatal attraction. Poe, Randall; Courter, Carol Lee // Across the Board;Oct95, Vol. 32 Issue 9, p7 

    Reports on the dangers posed by the V. vulnificus bacteria in oysters for people with high risks for liver diseases.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics